The oral agents used in the treatment of diabetes include metformin, sulfonylureas, dipeptidyl peptidase-4 (DPP-4) inhibitors, SGLT-2 inhibitors, and glucagon-like peptide-1 (GLP-1) receptor agonists [25]. This evidence concerns the gene SLC5A2 and diabetes mellitus.